HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xudong Zhang Selected Research

Ligands

1/2021CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling.
11/2019MiR-146a Deletion Protects From Bone Loss in OVX Mice by Suppressing RANKL/OPG and M-CSF in Bone Microenvironment.
12/2014UPR decreases CD226 ligand CD155 expression and sensitivity to NK cell-mediated cytotoxicity in hepatoma cells.
10/2014Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma.
4/2012The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xudong Zhang Research Topics

Disease

115Neoplasms (Cancer)
05/2024 - 08/2009
26Lymphoma (Lymphomas)
03/2024 - 09/2011
14Breast Neoplasms (Breast Cancer)
03/2023 - 11/2013
13Neoplasm Metastasis (Metastasis)
11/2023 - 11/2013
12T-Cell Lymphoma (Lymphoma, T Cell)
03/2024 - 08/2014
12Carcinogenesis
01/2024 - 01/2014
12Inflammation (Inflammations)
10/2023 - 01/2016
9Hepatocellular Carcinoma (Hepatoma)
01/2022 - 03/2014
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2023 - 01/2015
7Carcinoma (Carcinomatosis)
01/2022 - 06/2013
6Infections
05/2024 - 01/2009
6Wounds and Injuries (Trauma)
04/2024 - 11/2018
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2017
6Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 01/2014
5Heart Failure
03/2022 - 01/2018
4Fibrosis (Cirrhosis)
03/2024 - 01/2015
4Hypoxia (Hypoxemia)
03/2024 - 01/2018
4Ameloblastoma
12/2023 - 07/2017
4Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2017
4Colonic Neoplasms (Colon Cancer)
01/2022 - 07/2010
4Reperfusion Injury
01/2022 - 01/2014
4Lung Neoplasms (Lung Cancer)
11/2020 - 04/2015
4Body Weight (Weight, Body)
10/2020 - 12/2012
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020 - 11/2015
4Liver Neoplasms (Liver Cancer)
08/2018 - 03/2014
3Osteoarthritis
05/2024 - 01/2017
3Hodgkin Disease (Hodgkin's Disease)
03/2024 - 01/2023
3Disease Progression
01/2024 - 01/2019
3Acute Kidney Injury (Acute Renal Failure)
09/2023 - 01/2022
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2023 - 06/2020
3Glioma (Gliomas)
01/2023 - 02/2019
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2023 - 06/2019
3Stomach Neoplasms (Stomach Cancer)
12/2022 - 04/2011
3Rhinitis
07/2021 - 08/2014
3Necrosis
05/2019 - 10/2015
3Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 01/2017
3Esophageal Neoplasms (Esophageal Cancer)
12/2014 - 01/2012
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2024 - 01/2021

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
12/2023 - 04/2011
20Biomarkers (Surrogate Marker)IBA
01/2024 - 03/2014
13Long Noncoding RNAIBA
12/2022 - 02/2015
13Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2012
11MicroRNAs (MicroRNA)IBA
01/2023 - 01/2018
10Immune Checkpoint InhibitorsIBA
02/2024 - 01/2018
10Doxorubicin (Adriamycin)FDA LinkGeneric
07/2023 - 04/2015
10GemcitabineFDA Link
01/2022 - 01/2011
8Small Interfering RNA (siRNA)IBA
01/2023 - 01/2012
8Messenger RNA (mRNA)IBA
01/2023 - 06/2013
8Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 11/2014
7Insulin (Novolin)FDA Link
11/2022 - 01/2018
7pegaspargase (Oncaspar)FDA Link
01/2022 - 11/2014
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 01/2017
6tocophersolanIBA
05/2018 - 12/2012
5Therapeutic UsesIBA
01/2024 - 01/2014
5Interleukin-6 (Interleukin 6)IBA
08/2023 - 11/2019
5Etoposide (VP 16)FDA LinkGeneric
01/2023 - 01/2019
5RNA (Ribonucleic Acid)IBA
01/2023 - 12/2015
5LigandsIBA
01/2021 - 04/2012
5Docetaxel (Taxotere)FDA Link
11/2014 - 12/2012
4Circular RNAIBA
05/2024 - 12/2020
4AntigensIBA
05/2024 - 05/2018
4Chimeric Antigen ReceptorsIBA
01/2024 - 11/2015
4EnzymesIBA
01/2024 - 01/2014
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2018
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 06/2013
4VaccinesIBA
09/2020 - 08/2009
4Phosphorus (Red Phosphorus)IBA
09/2020 - 01/2017
4Prednisone (Sone)FDA LinkGeneric
01/2020 - 01/2017
4Thalidomide (Thalomid)FDA Link
01/2020 - 01/2017
4Adenosine Triphosphate (ATP)IBA
01/2018 - 10/2015
4DNA (Deoxyribonucleic Acid)IBA
07/2017 - 03/2012
3CytokinesIBA
03/2024 - 12/2016
3HydrogelsIBA
10/2023 - 01/2019
3Methotrexate (Mexate)FDA LinkGeneric
04/2023 - 11/2013
3fotemustine (Muphoran)IBA
01/2023 - 11/2018
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2023 - 11/2018
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2023 - 01/2014
3B7-H1 AntigenIBA
01/2022 - 01/2018
3Biocompatible Materials (Biomaterials)IBA
01/2022 - 09/2014
3CateninsIBA
10/2021 - 01/2018
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2021 - 01/2017
3apatinibIBA
02/2021 - 03/2018
3Hematoxylin (Haematoxylon)IBA
11/2020 - 12/2012
3Eosine Yellowish-(YS) (Eosin)IBA
11/2020 - 12/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 04/2012
3Vincristine (Oncovin)FDA LinkGeneric
01/2020 - 01/2017
3polydopamineIBA
01/2018 - 01/2016
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018 - 11/2015
3Chloroquine (Aralen)FDA LinkGeneric
01/2017 - 01/2014
2Propofol (Diprivan)FDA LinkGeneric
06/2024 - 01/2021
2CollagenIBA
04/2024 - 12/2021
2Polysaccharides (Glycans)IBA
03/2024 - 04/2020
2LipidsIBA
03/2024 - 09/2019

Therapy/Procedure

44Therapeutics
02/2024 - 09/2011
23Drug Therapy (Chemotherapy)
01/2024 - 06/2013
20Immunotherapy
05/2024 - 08/2009
13Radiotherapy
01/2024 - 11/2013
4Lasers (Laser)
02/2020 - 09/2014
3Transplantation
01/2024 - 09/2018
3Quantum Dots (Quantum Dot)
09/2020 - 01/2019